Boston IVF

Boston IVF is a leading fertility clinic network founded in 1986, making it one of the first freestanding IVF centers in the United States. Headquartered in Waltham, Massachusetts, it has grown into one of New England's largest fertility networks, operating over 20 locations across New England and New York. Since its founding, an average of 11 Boston IVF babies have been born each day.

The clinic offers a comprehensive range of reproductive services including In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), and fertility preservation. It serves a broad and diverse patient base, including straight couples, single individuals, and LGBTQ+ families. Key leadership includes Co-Founder and Medical Director Dr. Michael Alper and Surgical Director Dr. Alan S. Penzias.

Boston IVF maintains strong academic and research affiliations with institutions including Harvard Medical School, Beth Israel Deaconess Medical Center, Brown's Warren Alpert Medical School, Dartmouth's Geisel School of Medicine, and SUNY Upstate Medical University. This research foundation underpins the clinic's commitment to emerging reproductive technologies and improved patient success rates.

In a recent acquisition, IVI RMA — one of the largest reproductive medicine groups in the world — acquired Boston IVF's parent (Eugin Group's North American operations) for $535M. The deal added over 600 employees across 13 labs and 32 satellite offices to IVI RMA's global network, though Boston IVF continues to operate under its existing brand name. Innovations in reproductive medicine, fertility science, or patient care technology are highly relevant to this organization.